Developer docs
API playgroundTry for free, no card

Search company profiles

Lightship

Full company profile

uuid0000dos

Namestring
Lightship
Legal namestring
Lightship Inc.
Websiteurl
lightship.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Lightship Inc. is a US-headquartered clinical trial site organization founded in 2018 that delivers decentralized, hybrid, and community-based clinical trials to biopharmaceutical sponsors, contract research organizations (CROs), and academic institutions across the United States and the United Kingdom. The company operates a curated network of 30+ research sites with investigator medical licensure across 26 states (extending to 51 states via its virtual site model), complemented by mobile research units (MRUs) capable of in-community biospecimen collection, IMP storage, ECG, and physical assessments, and a dedicated GCP-trained mobile nursing service that has conducted 1,000+ offsite visits. Its reported operational metrics include 3x patient reach versus traditional brick-and-mortar trials, 2x faster trial startup, 95% patient retention in hybrid/DCT trials, 40% diverse patient enrollment, and 2.5x faster enrollment in decentralized studies.

Short descriptiontext

Lightship is a US clinical trial site organization that runs decentralized, hybrid, and community-based trials for biopharmaceutical sponsors, CROs, and academic institutions through a 30+ site national network, mobile research units, and dedicated GCP-trained mobile nursing services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
decentralized clinical trials, hybrid clinical trial services, mobile research units, mobile nursing services, clinical trial site network
Industry2 codes
PRIMARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
Product category
Clinical Trial Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Services
TypeProfessional Services
Description

Lightship generates revenue by providing end-to-end clinical trial services to biopharmaceutical sponsors, CROs, and academic institutions. Services include decentralized trials, hybrid trials, mobile research units, mobile nursing, community outreach, and site network management. Revenue is earned through service contracts for study delivery.

lightship.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Lightship is a clinical trial site organization that delivers decentralized, hybrid, and community-based clinical trials through a network of 30+ research sites, fully equipped mobile research units, and GCP-trained mobile nursing services. The company provides end-to-end trial services including outreach and recruitment, virtual site operations, in-home visits, and traditional site-based conduct for biopharmaceutical sponsors, CROs, and academic institutions across the US and UK.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 3x patient access compared to traditional brick-and-mortar trials
+7 more records
Product overview1 text field

Lightship is a clinical trial site organization offering a unified platform with multiple service modules for decentralized, hybrid, and traditional clinical trial delivery. The core offering includes: Outreach & Recruitment for community engagement; Decentralized Clinical Trials for fully remote studies; Hybrid Trial Services combining site-based and remote participation; Mobile Research Units (MRU) for community-based visits; Mobile Nursing Services for in-home care; and the Lightship Site Network of 30+ curated research sites. These services can be deployed independently or integrated for end-to-end trial support, from enrollment through close-out, across in-clinic, hybrid, and fully decentralized settings.

Product and service6 records
1Outreach & Recruitment
CategoryClinical Trial Patient Recruitment
Description

Community-driven engagement and multi-channel recruitment strategies that maximize clinical trial outreach through local events, partnerships, and digital outreach to identify, qualify, and refer eligible participants. Designed for biopharmaceutical sponsors, CROs, and academic institutions seeking representative patient populations.

2Decentralized Clinical Trials
CategoryDecentralized Clinical Trial Services
Description

End-to-end decentralized services that extend trial reach beyond traditional sites with virtual site models, licensed investigators across 51 US states, and GCP-trained research nurses delivering personalized care at home or participants' preferred locations. Designed for biopharma sponsors needing faster enrollment across geographically and demographically diverse populations.

3Hybrid Trial Services
CategoryHybrid Clinical Trial Services
Description

Clinical trial services that blend site-based and remote participation for high-quality research, combining traditional site visits with decentralized elements through a network of 30+ research sites across the US. Targeted at sponsors running trials that require both in-clinic and at-home activities.

4Mobile Research Units (MRU)
CategoryMobile Clinical Trial Infrastructure
Description

Fully functional, FDA-compliant portable research sites that bring clinical trials directly to participants, eliminating travel barriers and providing controlled environments for study visits, biospecimen collection, IMP storage, ECGs, and physical exams. Used by biopharma sponsors and CROs to reach communities lacking convenient trial sites.

5Mobile Nursing Services
CategoryHome-Based Clinical Trial Nursing
Description

GCP-qualified research nurses providing in-home and alternative-location visits for study activities including patient education, vital sign assessments, biological sample collection, IMP administration, and telemedicine assessments. Designed for sponsors running decentralized and hybrid trials requiring consistent, high-quality home-based care.

6Lightship Site Network
CategoryClinical Trial Site Network
Description

A curated network of 30+ research sites across the US with experienced investigators, providing geographic coverage and investigator medical licensure across 26 states with expertise across 10+ therapeutic areas. Used by biopharma sponsors and CROs to run site-based portions of decentralized and hybrid trials.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-18
Description

Lightship selected and implemented CRIO's integrated eSource and site CTMS platform to standardize site workflows and strengthen operational visibility across its expanding site network. The platform centralizes study operations, reporting, and oversight workflows for repeatable execution.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-04
Description

Lightship acquired Veda Trials, a company specializing in end-to-end clinical operations in community care settings. Veda's technology streamlines site activation and reduces operational burden for community clinics. Veda's Founder and CEO Lesley Solomon continues in her role reporting to Lightship CEO David MacMurchy. The acquisition expands Lightship's community-based operations and accelerates startup timelines.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-16
Description

IGC Pharma expanded its Phase 2 CALMA trial with Dominion Medical Associates, a site within Lightship's network. The hybrid trial model enhances participant access, retention, and enrollment efficiency across underserved and rural communities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-25
Description

Lightship joined SCRS as a Global Impact Partner. As a GIP, Lightship participates on the GIP Board and works with SCRS Leadership Council to champion sites within the global research marketplace, shape industry best practices, and advocate for greater site sustainability.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-07-08
Description

Lightship and Circuit Clinical mutually agreed to terminate their previously announced merger agreement following careful consideration of recent developments and thorough review of strategic priorities. Both companies will continue operating as separate entities.

6Dominion Medical Associates
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Richmond, Virginia-based clinical research site within Lightship's site network, led by Founder and Principal Investigator Dr. Richard Allen Jackson. Uses hybrid model combining in-clinic assessments with remote and in-home participant activities as part of Lightship's expanded access clinical trial model.

lightship.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct decentralized clinical trial competitor offering a unified DCT operating model with mobile nurses, telemedicine PIs, and home-based visits. Closest comparable in scope and target customer set to Lightship.

TypeDirect peer
Description

Hybrid clinical trial site network and former Lightship merger counterparty. Operates community-based research sites and was pursuing a comparable DCT/site network thesis before the merger was terminated.

TypeDirect peer
Description

DCT platform enabling decentralized trials through eCOA, eConsent, telehealth, and remote data capture. Competes with Lightship's virtual site and eSource capabilities and serves the same biopharma sponsors and CROs.

TypeDirect peer
Description

Multi-site clinical research site network operating dedicated research clinics across therapeutic areas. Direct competitor in the hybrid trial site network segment with overlapping biopharma sponsors and therapeutic focus.

TypeDirect peer
Description

Research-ready site network using Goes Direct approach to embed trials into community physician practices. Comparable model of leveraging community providers to expand trial access and diversity.

TypeDirect peer
Description

DCT-focused eClinical platform providing eConsent, EDC, eCOA, and decentralized trial enablement. Competes in the technology layer that supports hybrid and decentralized trial execution for sponsors and CROs.

TypeBroad incumbent
Description

Global CRO and life sciences services giant with extensive DCT capabilities, site network, and biopharma sponsor relationships. Competes broadly with Lightship across decentralized trial delivery at greater scale.

TypeBroad incumbent
Description

Global CRO formed through PRA Health Sciences combination, offering decentralized and hybrid trial services alongside full clinical development capabilities. Established incumbent competing for the same enterprise sponsors.

TypeBroad incumbent
Description

Large CRO with central labs, decentralized trial offerings, and site network capabilities. Competes with Lightship on hybrid trial delivery and patient access for biopharmaceutical sponsors.

TypeBroad incumbent
Description

Global CRO offering clinical development and decentralized trial services. Previously Lightship CBO's prior employer; established player competing on hybrid trial design and execution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lightship

Clinical Trial Serviceslightship.com

Lightship is a US clinical trial site organization that runs decentralized, hybrid, and community-based trials for biopharmaceutical sponsors, CROs, and academic institutions through a 30+ site national network, mobile research units, and dedicated GCP-trained mobile nursing services.

What Lightship does

Lightship Inc. is a US-headquartered clinical trial site organization founded in 2018 that delivers decentralized, hybrid, and community-based clinical trials to biopharmaceutical sponsors, contract research organizations (CROs), and academic institutions across the United States and the United Kingdom. The company operates a curated network of 30+ research sites with investigator medical licensure across 26 states (extending to 51 states via its virtual site model), complemented by mobile research units (MRUs) capable of in-community biospecimen collection, IMP storage, ECG, and physical assessments, and a dedicated GCP-trained mobile nursing service that has conducted 1,000+ offsite visits. Its reported operational metrics include 3x patient reach versus traditional brick-and-mortar trials, 2x faster trial startup, 95% patient retention in hybrid/DCT trials, 40% diverse patient enrollment, and 2.5x faster enrollment in decentralized studies.

Lightship firmographics

Firmographics
Name
Lightship
Legal name
Lightship Inc.
Website
https://lightship.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Lightship is a US clinical trial site organization that runs decentralized, hybrid, and community-based trials for biopharmaceutical sponsors, CROs, and academic institutions through a 30+ site national network, mobile research units, and dedicated GCP-trained mobile nursing services.
Ownership category
akta.pro rank

Lightship industry classification

Industry
Product category
Clinical Trial Services
akta.pro industry
PRIMARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)

Keywords

  • Decentralized clinical trials
  • Hybrid clinical trial services
  • Mobile research units
  • Mobile nursing services
  • Clinical trial site network

Where Lightship is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Lightship business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Trial Services: Lightship generates revenue by providing end-to-end clinical trial services to biopharmaceutical sponsors, CROs, and academic institutions. Services include decentralized trials, hybrid trials, mobile research units, mobile nursing, community outreach, and site network management. Revenue is earned through service contracts for study delivery.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Lightship product offering

Product offering

Core offering

Lightship is a clinical trial site organization that delivers decentralized, hybrid, and community-based clinical trials through a network of 30+ research sites, fully equipped mobile research units, and GCP-trained mobile nursing services. The company provides end-to-end trial services including outreach and recruitment, virtual site operations, in-home visits, and traditional site-based conduct for biopharmaceutical sponsors, CROs, and academic institutions across the US and UK.

Product overview

Lightship is a clinical trial site organization offering a unified platform with multiple service modules for decentralized, hybrid, and traditional clinical trial delivery. The core offering includes: Outreach & Recruitment for community engagement; Decentralized Clinical Trials for fully remote studies; Hybrid Trial Services combining site-based and remote participation; Mobile Research Units (MRU) for community-based visits; Mobile Nursing Services for in-home care; and the Lightship Site Network of 30+ curated research sites. These services can be deployed independently or integrated for end-to-end trial support, from enrollment through close-out, across in-clinic, hybrid, and fully decentralized settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Outreach & Recruitment Community-driven engagement and multi-channel recruitment strategies that maximize clinical trial outreach through local events, partnerships, and digital outreach to identify, qualify, and refer eligible participants. Designed for biopharmaceutical sponsors, CROs, and academic institutions seeking representative patient populations.
  • Decentralized Clinical Trials End-to-end decentralized services that extend trial reach beyond traditional sites with virtual site models, licensed investigators across 51 US states, and GCP-trained research nurses delivering personalized care at home or participants' preferred locations. Designed for biopharma sponsors needing faster enrollment across geographically and demographically diverse populations.
  • Hybrid Trial Services Clinical trial services that blend site-based and remote participation for high-quality research, combining traditional site visits with decentralized elements through a network of 30+ research sites across the US. Targeted at sponsors running trials that require both in-clinic and at-home activities.
  • Mobile Research Units (MRU) Fully functional, FDA-compliant portable research sites that bring clinical trials directly to participants, eliminating travel barriers and providing controlled environments for study visits, biospecimen collection, IMP storage, ECGs, and physical exams. Used by biopharma sponsors and CROs to reach communities lacking convenient trial sites.
  • Mobile Nursing Services GCP-qualified research nurses providing in-home and alternative-location visits for study activities including patient education, vital sign assessments, biological sample collection, IMP administration, and telemedicine assessments. Designed for sponsors running decentralized and hybrid trials requiring consistent, high-quality home-based care.
  • Lightship Site Network A curated network of 30+ research sites across the US with experienced investigators, providing geographic coverage and investigator medical licensure across 26 states with expertise across 10+ therapeutic areas. Used by biopharma sponsors and CROs to run site-based portions of decentralized and hybrid trials.

Quantifiable outcome

  • 3x patient access compared to traditional brick-and-mortar trials
  • +7 more outcomes

Companies that use Lightship

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Lightship technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature4 records

Lightship partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • CRIOcoreTechnology or Integration · 18 February 2026Lightship selected and implemented CRIO's integrated eSource and site CTMS platform to standardize site workflows and strengthen operational visibility across its expanding site network. The platform centralizes study operations, reporting, and oversight workflows for repeatable execution.
  • Veda TrialscoreStrategic or Co-development Partner · 4 February 2026Lightship acquired Veda Trials, a company specializing in end-to-end clinical operations in community care settings. Veda's technology streamlines site activation and reduces operational burden for community clinics. Veda's Founder and CEO Lesley Solomon continues in her role reporting to Lightship CEO David MacMurchy. The acquisition expands Lightship's community-based operations and accelerates startup timelines.
  • IGC PharmaminorStrategic or Co-development Partner · 16 January 2026IGC Pharma expanded its Phase 2 CALMA trial with Dominion Medical Associates, a site within Lightship's network. The hybrid trial model enhances participant access, retention, and enrollment efficiency across underserved and rural communities.
  • Society for Clinical Research Sites (SCRS)coreStrategic or Co-development Partner · 25 August 2025Lightship joined SCRS as a Global Impact Partner. As a GIP, Lightship participates on the GIP Board and works with SCRS Leadership Council to champion sites within the global research marketplace, shape industry best practices, and advocate for greater site sustainability.
  • Circuit ClinicalminorStrategic or Co-development Partner · 8 July 2025Lightship and Circuit Clinical mutually agreed to terminate their previously announced merger agreement following careful consideration of recent developments and thorough review of strategic priorities. Both companies will continue operating as separate entities.
  • Dominion Medical AssociatescoreChannel Partner/ Reseller/ DistributorRichmond, Virginia-based clinical research site within Lightship's site network, led by Founder and Principal Investigator Dr. Richard Allen Jackson. Uses hybrid model combining in-clinic assessments with remote and in-home participant activities as part of Lightship's expanded access clinical trial model.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Lightship competitors and assessment

Company assessment

Direct peers

  • Science 37: Direct decentralized clinical trial competitor offering a unified DCT operating model with mobile nurses, telemedicine PIs, and home-based visits. Closest comparable in scope and target customer set to Lightship.
  • Circuit Clinical: Hybrid clinical trial site network and former Lightship merger counterparty. Operates community-based research sites and was pursuing a comparable DCT/site network thesis before the merger was terminated.
  • Medable: DCT platform enabling decentralized trials through eCOA, eConsent, telehealth, and remote data capture. Competes with Lightship's virtual site and eSource capabilities and serves the same biopharma sponsors and CROs.
  • Velocity Clinical Research: Multi-site clinical research site network operating dedicated research clinics across therapeutic areas. Direct competitor in the hybrid trial site network segment with overlapping biopharma sponsors and therapeutic focus.
  • Elligo Health Research: Research-ready site network using Goes Direct approach to embed trials into community physician practices. Comparable model of leveraging community providers to expand trial access and diversity.
  • Castor: DCT-focused eClinical platform providing eConsent, EDC, eCOA, and decentralized trial enablement. Competes in the technology layer that supports hybrid and decentralized trial execution for sponsors and CROs.

Broad incumbents

  • IQVIA: Global CRO and life sciences services giant with extensive DCT capabilities, site network, and biopharma sponsor relationships. Competes broadly with Lightship across decentralized trial delivery at greater scale.
  • ICON plc: Global CRO formed through PRA Health Sciences combination, offering decentralized and hybrid trial services alongside full clinical development capabilities. Established incumbent competing for the same enterprise sponsors.
  • Labcorp Drug Development: Large CRO with central labs, decentralized trial offerings, and site network capabilities. Competes with Lightship on hybrid trial delivery and patient access for biopharmaceutical sponsors.
  • Syneos Health: Global CRO offering clinical development and decentralized trial services. Previously Lightship CBO's prior employer; established player competing on hybrid trial design and execution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Lightship social profiles

Digital presence

Lightship compliance and trust

Trust signal

Compliance2 records

Lightship financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lightship leadership team

Management profile

Number of profiles

Profiles8 records

Lightship subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Lightship funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lightship M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lightship

What does Lightship do?

Lightship is a clinical trial site organization that delivers decentralized, hybrid, and community-based clinical trials through a network of 30+ research sites, fully equipped mobile research units, and GCP-trained mobile nursing services. The company provides end-to-end trial services including outreach and recruitment, virtual site operations, in-home visits, and traditional site-based conduct for biopharmaceutical sponsors, CROs, and academic institutions across the US and UK.

Is Lightship a public or private company?

Lightship is a private company. It is classified as venture growth investor backed and is currently operating.

When was Lightship founded?

Lightship was founded in 2018. It employs 51 to 100 people.

Where is Lightship based?

Lightship is headquartered in Durham, United States, in the North America region.

How does Lightship make money?

One revenue line is on record: clinical Trial Services.

Who are Lightship's main competitors?

Direct peers on record are Science 37, Circuit Clinical, Medable, Velocity Clinical Research, Elligo Health Research and Castor. Broad incumbents are IQVIA, ICON plc, Labcorp Drug Development and Syneos Health.

Does Lightship have an API?

No public API is recorded for Lightship.

What industry is Lightship in?

Lightship's product category is Clinical Trial Services. Its primary akta.pro industry code is HLACAOAL, Decentralized/Hybrid Trial Enablement (DCT) Platforms, with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooLightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research DeliveryLightship Inc. announced the acquisition of Veda Trials, a company specializing in end-to-end clinical operations delivered in community care settings. The acquisition combines Veda's community-based operations model with Lightship's site network and mobile research services to expand reach into community clinics and accelerate enrollment for sponsors and health systems throughout the United States. Veda Trials will operate as part of Lightship's operations group, with integration priorities including aligning SOPs and training, and accelerating activation of existing Veda partner clinics.LightshipLightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research DeliveryLightship Inc. announced the acquisition of Veda Trials, a company specializing in end-to-end clinical operations in community care settings, to strengthen its ability to reach diverse patient populations and accelerate trial enrollment across the United States. The deal combines Veda's community-based operations model with Lightship's site network, hybrid delivery model, and mobile research services to compress startup timelines and reduce operational burden for community clinics. Veda Trials, originally backed by Redesign Health as its first institutional investor, will operate as part of Lightship's operations group with Founder and CEO Lesley Solomon continuing in her role.GlobeNewswireLightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research DeliveryLightship Inc. has acquired Veda Trials, a company specializing in end-to-end clinical operations in community care settings, with the transaction intended to strengthen Lightship's ability to reach representative participant populations and accelerate enrollment. Veda Trials, originally backed by Redesign Health, enables clinics and local providers to run clinical trials by simplifying day-to-day trial execution through technology that reduces operational burden. The combined entity will operate under Lightship's structure with Veda's Founder and CEO Lesley Solomon reporting to Lightship CEO David MacMurchy, and near-term priorities include aligning standard operating procedures and accelerating activation of existing Veda partner clinics.BioSpaceLightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research DeliveryLightship Inc. announced on February 4, 2026 the acquisition of Veda Trials, a company specializing in end-to-end clinical operations delivered in community care settings, expanding Lightship's ability to reach representative patient populations across the United States. Veda Trials, originally backed by Redesign Health, enables community clinics and local providers to run clinical trials through technology that streamlines site activation and reduces operational burden. The combined entity will offer sponsors unified operational playbooks, mobile research services, and flexible visit models including on-site, near-home, and in-home options to accelerate enrollment while maintaining data quality.StartupSeekerLightship - Funding: $100M+Lightship, a company founded in 2018 and based in El Segundo, has raised over $100 million in funding to support its community-based clinical trial solutions. The company focuses on removing geographic barriers and increasing diversity in clinical research through decentralized, hybrid, and mobile trial approaches.LightshipExpanding Clinical Trial Access: Lightship’s CEO David MacMurchy on The Healthcare Technology ReportLightship's CEO David MacMurchy discussed the company's mission to expand access to clinical trials through innovative engagement models in an episode of The Healthcare Technology Report podcast. The company's flexible model, which includes mobile research units and virtual trials, aims to reduce barriers to participation for underrepresented communities, achieving a retention rate of 96%. Lightship seeks to address structural inequities in clinical trial access while improving outcomes for historically marginalized populations.YouTubeExpanding Clinical Trial Access: Lightship’s David MacMurchyThe Healthcare Technology Report published an episode featuring David MacMurchy, CEO of Lightship, discussing the company's mission to expand access and representation in clinical trials. Lightship partners with biopharma companies, CROs, and academic institutions to deliver traditional, hybrid, and decentralized trials using mobile research units and in-home nursing services.YouTubeExpanding Clinical Trial Access: Lightship’s David MacMurchyLightship, led by CEO David MacMurchy, focuses on enhancing access and representation in clinical trials. The company collaborates with biopharma, CROs, and academic institutions to conduct various types of trials, including traditional and decentralized ones. MacMurchy aims to ensure that clinical trials better reflect real-world populations.The Achievers ShowExpanding Clinical Trial Access: Lightship’s David MacMurchyDavid MacMurchy, CEO of Lightship, appeared on The Healthcare Technology Report to discuss his company's mission to increase access and representation in clinical research. Founded in 2018, Lightship partners with biopharma companies, CROs, and academic institutions to deliver traditional, hybrid, and decentralized trials through mobile units and in-home nursing services.CircuitclinicalCircuit Clinical and Lightship Agree to Terminate MergerCircuit Clinical and Lightship have mutually agreed to terminate their previously announced merger agreement. The decision follows a review of strategic priorities, with both companies citing changes in market dynamics as the reason for continuing operations independently. Both organizations stated they remain focused on their respective missions and long-term objectives.